A growing movement within the UK Parliament is seeking to overhaul the approach to diagnosing and treating chronic urinary tract infections (UTIs), a condition that affects millions and can lead to severe, ongoing pain and distress. The All-Parliamentary Group (APPG) on UTIs, co-chaired by MPs Allison Gardner and Luke Taylor, is pushing for critical changes, including the establishment of a formal, standardized medical definition for chronic UTIs, which currently does not exist.
Chronic UTIs are defined as persistent infections that do not clear with short courses of antibiotics and often do not register on standard urine tests. This diagnostic challenge leads to significant delays in treatment and leaves many patients battling debilitating symptoms without proper support. Symptoms can include burning pain during urination, abdominal pain, intense urgency to urinate, and cloudy or blood-tinged urine. If the infection spreads to the kidneys, it can cause fever, chills, nausea, and back pain.
Lisa Sawers, a 54-year-old yoga instructor, shared her experience of suffering from chronic UTIs since her twenties, with symptoms becoming excruciating and unremitting in her forties. Her condition has led to constant pain, inflammation, and a significant disruption to her daily life, impacting her ability to work, socialize, and even sleep. Sawers has sought help from over 20 specialists, incurring substantial costs, but initially received dismissive responses due to consistently negative standard urine tests. The lack of a clear diagnosis left her feeling belittled and ignored.
"I get through the days, but it has changed the entire landscape of my life," Sawers stated. "I constantly walk around with ice-packs pressed into my legs and pelvis to reduce the inflammation; at other times I have purple marks on my legs from holding hot-water bottles against them to help with the pain." She added that painkillers offered little relief and the condition kept her awake most nights.
The APPG's agenda includes advocating for specialist NHS clinics, clearer diagnostic criteria for chronic and recurrent cases, and a formal definition for the condition. The group is also examining instances where pharmacies may refuse to prescribe antibiotics for UTIs, referring patients back to general practitioners, with the aim of potentially widening eligibility for timely treatment.
Factors increasing the risk of UTIs include female anatomy, with women having a shorter urethra making it easier for bacteria to reach the bladder. Other risk factors encompass catheter use, menopause-induced hormonal changes, kidney stones, a weakened immune system, and sexual intercourse. The psychological toll can be severe, with a 2021 report from Chronic UTI Australia indicating that one in ten individuals with chronic UTIs contemplate suicide.
Current diagnostic methods, such as mid-stream urine cultures and dipstick tests, are known to be unreliable for detecting chronic, embedded infections. Studies suggest these tests can miss a significant percentage of chronic UTIs. Experts argue that the thresholds used for diagnosis are based on outdated research, potentially from the 1950s, and do not accurately reflect the complexities of chronic infections where bacteria may embed within the bladder wall and evade detection. Dr. Catriona Anderson, a GP and founder of Focus Medical Clinic, explained that standard tests are designed to detect acute, free-floating infections, not those that are embedded.
Beyond the diagnostic challenges, treatment is also complex. While antibiotics are the common initial approach, chronic UTIs can become resistant, and prolonged use can lead to side effects and disrupt the gut microbiome. Some patients, like Sawers, may not respond to antibiotics at all. Consultants like Steve Foley, a urological surgeon, suggest exploring non-antibiotic treatments and potentially using antibiotics more locally, directly into the bladder, rather than systemically.
There is a growing recognition that addressing chronic UTIs requires a multi-faceted approach, moving beyond simply identifying bacteria to understanding how the bladder interacts with them. Treatments being explored include methenamine hippurate (Hiprex), d-mannose, vaginal estrogen cream, lifestyle changes, and probiotics. The APPG's efforts aim to bring these issues to the forefront and drive systemic change in how chronic UTIs are managed in the UK.